Latest Regulatory Compliance News

Botala Energy Ltd has denied holding undisclosed information following a sharp share price rise, linking the spike to a recent Serowe CBM Project announcement and confirming compliance with ASX disclosure rules.

Avira Resources has cleared all major regulatory and heritage hurdles to kick off a 4,500-metre RC drilling campaign at its high-grade Mt Cattlin Gold Project, aiming for a maiden resource estimate by year-end.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) has had its trading suspension lifted as of 4 May 2026, following the lodgement of its delayed Annual Report revealing a $2.86 million net loss.

GR Production Services secures a five-year $57 million operations and maintenance contract at the Sturt Plateau Compression Facility in the Northern Territory's Beetaloo Basin, with potential extension for three more years.

Strickland Metals has laid out an ambitious 2026 drilling program at its Rogozna Project in Serbia, targeting resource expansion and Pre-Feasibility Study support, despite delays in government approvals for its Shanac license.

Botala Energy faces an ASX price query after its shares jumped from $0.055 to $0.073 amid heavy trading, prompting scrutiny over undisclosed information and continuous disclosure compliance.

Sequoia Financial Group has called off the sale of its InterPrac subsidiary to Conquest Investment Partners, citing unmet conditions and changed circumstances that made completion unviable. The company will now explore alternative strategic paths for InterPrac.

VanEck Investments Limited has released a comprehensive replacement Product Disclosure Statement for seven Australian bond ETFs, updating key details on investment strategies, risks, fees, and regulatory frameworks.

AKORA Resources has secured a 25-year mining permit for its flagship Bekisopa iron ore project, a critical step toward development, but faces suspension from ASX quotation due to late reporting.

WhiteHawk has secured Atturra as its first Australian enterprise partner for the Quixxi Clarity AI platform, aiming to accelerate AI governance adoption across government and enterprise sectors.

Kore Potash made steady progress on its Kola Potash Project in Q1 2026, completing key marine and topographic studies while navigating design revisions and ongoing financing talks. The company’s formal sale process continues with one bidder remaining active and cash reserves at US$8.3 million.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.